Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Apnea, Obstructive 1 Radiation Injuries 1 Lymphoma, Follicular 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Rituximab 67 Cyclophosphamide 39 Vincristine 33 Prednisone 31 Doxorubicin 25 Lenalidomide 18 Radiotherapy 16 Bendamustine Hydrochloride 14 Peripheral Blood Stem Cell Transplantation 10 Filgrastim 10 Etoposide 10 Prednisolone 8 tofacitinib 7 obinutuzumab 6 ibritumomab tiuxetan 6 fludarabine 6 VAP-cyclo protocol 6 Mitoxantrone 6 Methylprednisolone 6 Deoxycholic Acid 6 Cytarabine 6 Melphalan 5 Dexamethasone 5 Carmustine 5 ibrutinib 4 fludarabine phosphate 4 R-CHOP protocol 4 Methotrexate 4 Interferon-alpha 4 Idarubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Follicular × Mometasone Furoate × Clear all

NCT01671852 2015-07-30

Nasonex OSA

Children's & Women's Health Centre of British Columbia

Phase 3 Withdrawn

Lymphoma, Follicular, Sleep Apnea, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡